Under the collaboration, the two companies will carry out exclusive sales of the system, in addition to delivering joint training and services support.
Through the agreement, CSI and B3 will combine their operational experience in providing life-saving technologies in blast environments with the research, engineering and programmatic capabilities required to identify the risk of blast-induced Traumatic Brain Injury (TBI) and long-term neurological disorders.
According to clinical specialists, repetitive blast overpressure exposure has a clear connection with adverse effects on the brain and primary organs of the soldiers.
Senior military leaders are currently being directed to re-evaluate and study blast-exposure limits both during training and in combat.
The two firms use miniature sensors, waveform algorithms and exportable databases to deliver the tools required to catalogue the harmful pressure the loading service members experience while carrying out their duties.
Being armed with a service-wide database of incident metrics, unit leaders will be able to refine tactics in order to reduce unnecessary blast overpressure exposures.
In addition, military health experts can offer right treatments and veterans can receive the comprehensive long-term care they require.
CSI is an aerospace company focusing on delivering products that can be used for the safe detection, identification and mitigation of hidden explosive threats.
The technology company B3 focuses on developing sensor systems that can be used to preserve health, transform behaviour and optimise performance of the warfighters.